Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study백신 접종 후 모유 내 Anti-SARS-CoV-2 IgA 및 IgG는 백신 유형 및 이전 SARS-CoV-2 노출에 따라 다릅니다. 종단 연구Observational Study Published on 2022-04-212022-09-12 Journal: Genome Medicine [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] age anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibodies antibody AstraZeneca baseline BNT162b2 Breast breast milk ChAdOx1 nCoV-19 collected Course COVID-19 COVID-19 vaccination COVID-19 vaccine dependent on distribution dose evaluate first dose group healthcare human milk IgA IgA antibodies IgA level IgG IgG antibody immunoglobulins Infant lactating lactating women Level Moderna mother mRNA vaccine mRNA-1273 mRNA-based vaccine persistence prospective observational study Protective Protective antibody reactivity receiving SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection second dose Seven significantly higher Spain the vaccine transfer vaccination Vaccine Vaccines virus women [DOI] 10.1186/s13073-022-01043-9 PMC 바로가기 [Article Type] Observational Study
Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers실생활에서 코로나백의 약화 효과: 의료 종사자를 대상으로 한 후향적 코호트 연구Article Published on 2022-04-202022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted Alpha Alpha variant association booster dose booster doses clinical trials conducted CoronaVac COVID-19 COVID-19 disease COVID-19 infection COVID-19 infections COVID-19 vaccine Cox regression defined demonstrated determine dominant dose doses Effectiveness follow-up period groups Health care Health care worker health care workers Inactivated vaccine incidence rate İstanbul positive PCR test rate ratio receive receiving reduce retrospective cohort study SARS-COV-2 infection second dose test result the vaccine Turkey university hospital vaccination Vaccine vaccine effectiveness variant variants were used [DOI] 10.1016/j.vaccine.2022.03.032 PMC 바로가기 [Article Type] Article
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine Research Published on 2022-04-192022-10-05 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] acute respiratory syndrome Amino acid anti-viral response Asymptomatic Bacterial cellular coronavirus Coronavirus disease 2019 COVID-19 COVID-19 patients cytokine profile dendritic cell disease Donor effective Efficacy effort elicit elicited epitope experiment Health Human humoral immune responses immune response Immunity in vivo indicated introduced negative control NTD NTD domain pathogen peptide peptide-based vaccine performed positive control predominant Protein provided Receptor binding domain Research SARS-CoV-2 SARS-CoV-2 vaccine subjects tested the Spike the vaccine Vaccine vaccine candidate Vaccines Validity volunteers [DOI] 10.1038/s41598-022-09615-w [Article Type] Research
Vaccine hunters and jostlers may have hurt the COVID-19 vaccination effort Research Published on 2022-04-162022-10-05 Journal: Scientific Reports [Category] 치료법, [키워드] Affect conducted COVID-19 vaccination COVID-19 vaccine effort experiment extreme groups help information MOST predict preference preferences public health authority risk secure the vaccine vaccination Vaccine vaccine dose [DOI] 10.1038/s41598-022-10348-z [Article Type] Research
Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patientsSARS-CoV-2에 대한 초기의 강력한 항체 반응은 COVID-19 환자의 질병 중증도를 예측합니다Article Published on 2022-04-152022-09-11 Journal: Journal of Translational Medicine [Category] COVID19(2023년), SARS, 바이오마커, 진단, 치료법, [키워드] antibody antibody levels Antibody profile Antibody Response Antibody responses Antibody-dependent enhancement Antigen Antigen microarray Biomarker Candidates cell activation Clinical significance correlated COVID-19 COVID-19 patient disease disease severity elicit epidemiological studies exacerbate frequencies Frequency full length healthy controls idea IgA IgA response IgA responses IgE IgG IgM response IgM responses implication levels of antibody mast cell Mast cells Mild disease MOST nonstructural protein nucleocapsid Pathogenesis pathogenesis of COVID-19 Patient patients with COVID-19 peak levels Planning predict Prevalence Prognosis prognostic Protein recent response Result risk S protein SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens sera serological studies SEROLOGICAL STUDY Serum level severe disease severity Spread Support testing antibody the disease the vaccine vaccine candidates virus with mild disease [DOI] 10.1186/s12967-022-03382-y PMC 바로가기 [Article Type] Article
Health workers’ Perceptions and REsponses in implementing COVID-19 Immunisation StratEgy in South Western Sydney (PRECISE): an observational studyObservational Study Published on 2022-04-152022-10-04 Journal: BMJ Open [Category] COVID19(2023년), SARS, 임상, [키워드] age Analysis categories Community COVID-19 COVID-19 vaccination COVID-19 vaccine Effectiveness female first dose Health Health policy health worker healthcare worker immunisation information majority median MOST over participant Patient Perception phase positive Public public health question receive receiving recipient reported response responses Seven South the vaccine Univariate analysis vaccination Vaccine vaccine dose was used [DOI] 10.1136/bmjopen-2021-055034 PMC 바로가기 [Article Type] Observational Study
Vaccinating Australia: How long will it take?호주 백신 접종: 얼마나 걸립니까?Article Published on 2022-04-142022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] Administered Analysis assumption Australia Cluster Community costly Coverage COVID-19 COVID-19 vaccination demographics dose Epidemic essence Government highlight initial key factor Local lockdown Logistic National per day Population Prevalence public health messaging reopening risk schedule speed supply the vaccine transmissible variant vaccinate Vaccinating vaccination Vaccine vaccine administration vaccine dose vaccine doses vaccine eligibility Vaccine hesitancy [DOI] 10.1016/j.vaccine.2021.07.006 PMC 바로가기 [Article Type] Article
Digital health literacy to share COVID-19 related information and associated factors among healthcare providers worked at COVID-19 treatment centers in Amhara region, Ethiopia: A cross-sectional surveyResearch article Published on 2022-04-142022-10-05 Journal: Informatics in Medicine Unlocked [Category] 치료법, [키워드] 95% CI acute respiratory syndrome Affect Analysis conducted CoV COVID-19 COVID-19 outbreak creating cross-sectional survey data entry Digital digital health literacy distribution E-health educational status Ethiopia Factor Health Healthcare provider help identify Improving indicated information less Logistic regression analysis P-value pandemic participated questionnaire reduce respiratory virus Result significantly SPSS statistical significance the vaccine Treatment was used were used [DOI] 10.1016/j.imu.2022.100934 [Article Type] Research article
Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events고해상도 접촉 네트워크를 사용하여 대규모 수일 이벤트에서 SARS-CoV-2 전송 및 제어 평가Article Published on 2022-04-122022-09-11 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, [키워드] activities close contact collected Contact country Coverage Crew Delta delta variant evaluate event High-resolution influence Intervention IQR Mask mask mandate Mask mandates median Outbreaks per day rapid antigen test Rapid antigen tests reduce required risk SARS-CoV-2 transmission SARS-CoV-2 variant social contact the vaccine Transmission unique vaccination [DOI] 10.1038/s41467-022-29522-y PMC 바로가기 [Article Type] Article
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study영국에서 SARS-CoV-2 오미크론(B.1.1.529) 및 델타(B.1.617.2) 변이와 관련된 입원 및 사망 위험 비교 분석: 코호트 연구Article Published on 2022-04-022022-09-11 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted adjusted hazard ratio Admission affected age Analysis B.1.1.529 B.1.617.2 booster booster vaccination Cohort cohort study Comparative analysis Council COVID-19 case dataset death decile delta variant demonstrated Department Deprivation dose doses Effectiveness Endpoint Engineering England estimate Ethnicity Evidence evidence of examined hazard hospital Hospital admission hospitalisation index individuals Infection infections Innovation intrinsic laboratory-confirmed maintain Medical Research Council moderate Mortality mRNA vaccine mRNA vaccines National offered omicron Omicron variant outcome primary analysis Protective provided reduction reduction in Relative risk resulting risk SARS-CoV-2 SARS-COV-2 infection Science severity Severity of infection Sex stratified the vaccine Transmissibility vaccinated individual vaccinated individuals vaccination Vaccination Status Vaccine variant variants Variation [DOI] 10.1016/S0140-6736(22)00462-7 PMC 바로가기 [Article Type] Article